TrialAlzheimer's research & therapy2022

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease.

Shobha Dhadda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.